利尔化学(002258) - 2022 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2022 reached ¥2,612,935,661.17, representing a 76.32% increase compared to ¥1,481,933,864.23 in the same period last year[3] - Net profit attributable to shareholders was ¥534,331,688.15, a significant increase of 142.02% from ¥220,781,407.74 year-on-year[3] - Basic earnings per share increased to ¥1.0143, reflecting a growth of 140.93% compared to ¥0.4210 in the same period last year[3] - Net profit for the current period was ¥591,086,437.05, compared to ¥245,143,801.01 in the previous period, reflecting an increase of approximately 141.5%[29] - The company reported a gross profit of ¥693,274,955.63, which is a significant increase from the previous period's gross profit of ¥278,246,058.82, representing an increase of approximately 149.5%[26] - The company’s total profit for the current period was ¥697,575,992.54, compared to ¥283,484,475.67 in the previous period, reflecting an increase of about 146.5%[26] Cash Flow - The net cash flow from operating activities was ¥204,771,003.87, up 170.19% from ¥75,788,109.36 in the previous year[3] - Cash inflow from operating activities totaled ¥1,771,206,934.98, compared to ¥1,077,868,134.56 in the previous period, showing an increase of approximately 64.4%[30] - Total cash outflow from operating activities amounted to $1,566,435,931.11, compared to $1,002,080,025.20 last year[33] - Cash inflow from investment activities was $10,223,931.69, significantly up from $2,674,432.02 in the prior year[33] - Net cash flow from financing activities improved to $106,501,060.07 from -$21,440,015.57 in the previous period[33] Assets and Liabilities - Total assets at the end of the reporting period were ¥11,203,104,813.36, a 9.49% increase from ¥10,232,167,212.33 at the end of the previous year[3] - Total current assets increased to CNY 5,356,798,646.92 from CNY 4,679,363,321.75, reflecting a growth of approximately 14.5%[14] - Total liabilities increased to CNY 4,991,961,194.45 from CNY 4,407,632,540.61, representing a rise of approximately 13.3%[22] - The company's equity attributable to shareholders rose to CNY 5,273,726,545.44 from CNY 4,977,230,721.13, an increase of about 6%[22] Operating Costs and Expenses - The company’s operating costs increased by 62.07% to ¥171,991.34, attributed to rising sales and costs of certain products[9] - Total operating costs amounted to ¥1,919,660,705.54, up from ¥1,203,687,805.41, indicating a rise of about 59.5%[26] - Research and development expenses for the current period were ¥62,723,198.01, up from ¥48,709,321.12, indicating an increase of about 28.8%[26] Investments and Other Income - The company reported a significant increase in investment income, which rose to ¥622,901.91 from ¥60,815.94, indicating a growth of approximately 925.5%[26] - The company reported a 51.57% increase in accounts receivable, reaching ¥192,106.41, due to business growth[6] - The company’s other non-current assets increased by 76.43% to ¥25,438.17, mainly due to prepayments for new project equipment[6] Future Outlook - The company plans to continue expanding its market presence and investing in new product development to sustain growth[28]